2014 | MicroRNA-196A-2 Polymorphisms and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B | 김휘영 | Article |
2019 | Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices | 김휘영 | Article |
2020 | Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease | 유권; 이정경; 김태헌; 류동열; 김휘영; 임지영; 김진실; 이혜아 | Article |
2017 | Noninvasive prediction of hemodynamic response to carvedilol therapy for primary prophylaxis in cirrhotic patients with esophageal varices: a prospective study | 김휘영 | Meeting Abstract |
2017 | Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients | 김지은; 김휘영 | Article |
2024 | PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B | 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
2023 | Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study | 김휘영 | Article |
2022 | Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration | 김휘영 | Article |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma | 유권; 김태헌; 김휘영 | Article |
2015 | Prospective Comparison of Noninvasive Fibrosis Assessment to Predict Advanced Fibrosis or Cirrhosis in Asian Patients With Hepatitis C | 김휘영 | Article |
2021 | Recent advances in nonalcoholic fatty liver disease metabolomics | 김휘영 | Review |
2015 | Reduction of Oxidative Stress Attenuates Lipoapoptosis Exacerbated by Hypoxia in Human Hepatocytes | 김휘영 | Article |
2020 | Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease | 유권; 김태헌; 김휘영; 이혜아 | Article |
2023 | Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease | 유권; 김태헌; 김휘영; 이민종; 이혜아; 전호수; 이한아 | Article |
2018 | Scoring system for risk stratification of viral reactivation during prophylactic antiviral treatment in Korean patients with hepatitis B undergoing anticancer chemotherapy: A multicenter study | 김휘영 | Article |
2016 | Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria | 김휘영 | Article |
2019 | Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial | 김휘영 | Article |
2024 | The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study | 김휘영; 이한아 | Article |
2019 | The Efficacy of Cone-Beam CT–Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization | 백승연; 유권; 김태헌; 최선영; 박상희; 김휘영; 김민욱 | Article |
2015 | The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients | 김휘영 | Article |
2023 | Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease | 김휘영; 이한아 | Review |
2023 | TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features | 김휘영; 이한아 | Article |
2021 | Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis | 유권; 김휘영; 이민종; 최아름; 전호수 | Review |
2019 | Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study | 김휘영; 남준열 | Article |
2015 | Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease | 김휘영 | Article |